
Esketamine (Spravato®) for Treatment-Resistant Depression
A TGA-approved prescription nasal spray, used with an oral antidepressant, offering an evidence-based option for adults with treatment-resistant depression.
- TGA-approved nasal spray (Spravato®)
- For adults with treatment-resistant depression
- Acts on the brain's glutamate system
- Self-administered under nursing supervision
- In-clinic treatment with medical monitoring
“Awarehub is a great clinic with a genuinely caring and professional team. They really take the time to get to know you and make sure the support fits your needs. You always feel respected and well looked after here!”
— Carla
Enquire Now
Fill in your details and we'll get back to you






How Esketamine Works
Unlike traditional antidepressants that target serotonin or noradrenaline pathways, esketamine acts on the brain's glutamate system. This specific mode of action helps enhance neuroplasticity (brain growth and change) and improve mood in clients who haven't responded to standard depression treatments.
Is Esketamine Right for You?
Esketamine may be considered for adults who:
- Have a diagnosis of Major Depressive Disorder (MDD).
- Have not achieved adequate relief after trialling two or more antidepressant treatments.
- Continue to experience functional impairment due to persistent symptoms.
- Can attend regular in-clinic administration and observation sessions.
Our psychiatrist will determine your suitability for esketamine through a comprehensive clinical assessment.

What to Expect During Treatment
Esketamine is administered exclusively within a controlled clinical environment under medical oversight.
In-Clinic Administration
The medication is self-administered as a nasal spray under direct nursing supervision.
2-Hour Monitoring Period
You will relax comfortably in a quiet room at the clinic for approximately one to two hours following administration.
Post-Treatment Precautions
Due to the sedative effects of esketamine, you must arrange transport home and refrain from driving or operating heavy machinery until the next day.

Treatment Protocol & Schedule
Treatment is delivered in structured phases, tailored to your clinical response:
Induction Phase (Weeks 1–4)
Involves 2 sessions per week, 48–72 hours apart.
Optimisation Phase (Weeks 5-8)
Transitions to 1 session per week.
Maintenance Phase
If you have responded to esketamine, you may be eligible for maintenance treatment. Sessions are tapered to weekly or fortnightly based on your ongoing clinical need.
Accessing Care
Please ask your GP or psychiatrist to send a referral for an initial psychiatric assessment at AwareHub. Our clinical team will collaborate with your referring doctor throughout your care to support your long-term health plan.
Please note that Medicare does not cover Esketamine treatment sessions; however, all your psychiatry reviews are billed at our standard clinic fees, and Medicare rebates will apply. The fee for esketamine treatment covers treatment administration and a two-hour observation period by our experienced nursing team.
Medical Disclaimer & Regulatory Notice
Spravato® (esketamine) is a Schedule 8 prescription medicine indicated for adults with Treatment-Resistant Depression. It is available strictly under the care and supervision of an AHPRA-registered specialist psychiatrist. Treatment suitability, dosing, and protocols are determined following a comprehensive clinical evaluation. Individual outcomes vary. In accordance with TGA guidelines, esketamine must be administered in an accredited clinical setting under direct medical observation, and patients must not drive or operate machinery until the day after treatment. This page is intended for general educational purposes and does not replace professional medical advice.



Esketamine — Frequently Asked Questions
Esketamine
Please reach out to us at AwareHub if you cannot find an answer to your question.
Contact us today to arrange a FREE 15-minute call with one of our experienced nurses to discuss TMS and Esketamine and how they may support your mental health treatment.
Enquire Now

AwareHub
1300 029 273AWAREHUB SYDNEY TMS & ESKETAMINE CLINIC
Suite 703/1 Newland Street, Bondi Junction, 2022, NSW, Australia
tms@awarehub.com.auAWAREHUB BUNDABERG TMS & ESKETAMINE CLINIC
The Friendlies Medical Suites, 70-72 Crofton Street, Bundaberg, 4670, QLD, Australia
BundabergTMS@awarehub.com.au